Literature DB >> 27020706

Key considerations in the treatment of von Hippel-Lindau disease.

Patrick G Pilié1, Eric Jonasch1, Ian E McCutcheon2.   

Abstract

Entities:  

Keywords:  hemangioblastoma; renal cell carcinoma; von Hippel-Lindau disease

Mesh：

Year:  2016        PMID： 27020706     DOI： 10.2217/fon-2016-0028

Source DB:  PubMed          Journal:  Future Oncol        ISSN： 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

1.  Von Hippel-Lindau disease with extramedullary and pancreatic involvement.

Authors:  Andrea Pantigozo-Rimachi; Giuliana Murillo-Díaz; Nilton Yhuri Carreazo; Victor Manuel Cucho Dávila
Journal:  Med J Armed Forces India       Date:  2020-05-07

2.  Pilot study of dovitinib in patients with von Hippel-Lindau disease.

Authors:  Patrick Pilié; Elshad Hasanov; Surena F Matin; Ashley H Henriksen Woodson; Valerie D Marcott; Shelly Bird; Rebecca S Slack; Gregory N Fuller; Ian E McCutcheon; Eric Jonasch
Journal:  Oncotarget       Date:  2018-05-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.